Oxford Immunotec Global PLC announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was USD 5.835 million compared to USD 19.588 million a year ago. Operating loss was USD 9.834 million compared to USD 981,000 a year ago. Net loss was USD 9.685 million compared to net income of USD 590,000 a year ago. Basic loss per share was USD 0.37 compared to basic earnings per share of USD 0.02 a year ago. For the half year, sales was USD 19.746 million compared to USD 34.377 million a year ago. Operating loss was USD 16.417 million compared to USD 4.330 million a year ago. Net loss was USD 15.712 million compared to USD 906,000 a year ago. Basic loss per share from continuing operations was USD 0.57 compared to USD 0.03 a year ago. Basic loss per share was USD 0.6 compared to USD 0.03 a year ago.